Latest kidney disease News | Page 7

PolyU researchers invent non-invasive diagnostic device Smart-CKD for advancing clinical management of chronic kidney disease
New drug shows promise in treating chronic kidney disease
Could many dementia cases actually be liver disease?
Proteomics International retains its ISO 13485 certification
Diabetes Australia takes research funding fight to Parliament
New study: Diabetes drug linked to fewer hospitalisations for infections, anemias and obstructive airway diseases
Dimerix announces successful collection of data for first patients in ACTION3 trial
One million people in England may have undiagnosed type 2 diabetes – what you need to know
New insight into old IBD drug could improve treatments
Largest study on genetic risk for type 2 diabetes published
Sixteenth anniversary of the National Apology to Australia’s Indigenous Peoples and Closing the Gap Annual Report and Implementation Plan
World-first discovery may enable an effective long-term lupus treatment
Capricorn Coast’s new dialysis unit step closer
New World-Class Dialysis Service Open At Monash Health
AMA Indigenous Medical Scholarship – spotlight on Dr Gemma Johnston
AUSTRALIAN WORLD-FIRST TRIAL OFFERS NEW HOPE FOR TYPE 1 DIABETES?
Dimerix’s ACTION3 investigational new drug approved in China
Study links deprivation with risk of dying from sepsis
Here’s what happens to your penis as you age
Drug screen points toward novel diabetes treatments
Boosting beta cells to treat Type 2 diabetes
9M and Q3 2023 results
Zibotentan/dapagliflozin combination demonstrated significant albuminuria reduction in patients with chronic kidney disease and proteinuria in ZENITH-CKD Phase IIb trial
ZORA real-world evidence demonstrates that Lokelma substantially increases cardiorenal patients’ chances of maintaining lifesaving RAASi therapy
Mater Researchers recognised at 2023 Mater People Awards
New hope to treat and reverse osteoarthritis
Breast cancer surgeon heads Mater People Awards winners
World-first human challenge trial to test efficacy of Strep A and rheumatic heart disease vaccine
Large-scale study reveals new genetic details of diabetes
Striving for equity in kidney health care
Dimerix and Advanz Pharma enter agreement to commercialise DMX-200 in major markets
Cow milk vs. alternative milk: what’s best?
Forxiga met primary endpoint in T2NOW Phase III trial, one of the largest paediatric type 2 diabetes studies performed to date
North Queensland’s first-ever kidney transplant service
US FDA grants conditional approval to the brand name of Dimerix’s DMX-200
Researchers join consortium to prevent type 2 diabetes in children
Is it really safe to feed your cat a vegan diet?
Mater Research’s Future Leaders Celebrated at Annual Symposium
NSW community urged to be on alert amid rise in listeriosis
Sugar tax key to addressing diabetes in Australia
PAEDS network provides crucial data on Strep A infections in Australia
AI helps ID cancer risk factors
Kidney disease patients needed for national trial
Big hypertension risk revealed in Top End First Nations study
AstraZeneca demonstrates scientific leadership with compelling new data at ESC Congress 2023 on the interconnections across chronic diseases
Forxiga approved in China to reduce the risk of cardiovascular death and hospitalisation in adult patients with symptomatic chronic heart failure
Tenders open for new $10.37m renal dialysis unit in Yeppoon
Ipswich Hospital opens Acute Haemodialysis Unit